ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2128

The Role of Insulin Resistance in the Development of Premature Atherosclerosis in Patients with Rheumatoid Arthritis

Gorica Ristic1, Vesna Subota2, Toplica Lepic3, Dejana Stanisavljevic4, Branislava Glisic1, Milan Petronijevic1, Arsen Ristic5 and Dusan Stefanovic1, 1Department of Rheumatology and Clinical Immunology, Military Medical Academy, Belgrade, Serbia, 2Institute of Medical Biochemistry, Military Medical Academy, Belgrade, Serbia, 3Department of Neurology, Military Medical Academy, Belgrade, Serbia, 4Institute of Medical Statistics, Belgrade University School of Medicine, Belgrade, Serbia, 5Department of Cardiology, Clinical Center of Serbia & Belgrade University School of Medicine, Belgrade, Serbia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Atherosclerosis, insulin resistance, intima medial thickness and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects III - Cardiovascular Disease and RA

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Accelerated atherosclerosis in rheumatoid arthritis (RA) is well established but the role of insulin resistance in RA pts without diabetes or metabolic syndrome remains to be determined. Therefore, the aim of our study was to investigate the prevalence of insulin resistance in RA pts with normal glycoregulation and its association with carotid intima-media thickness (IMT) and therapy exposure.

Methods: Our study population included 90 RA pts (age 52.4±9.9 yrs, 86.7% females, disease duration 9 yrs, range 4-13). We determined body mass index (BMI), waist circumference (WC), blood pressure, smoking habits, and disease activity score (mDAS28-SE). IMT was measured bilaterally, at common carotid (CCA), bifurcation (BF), and internal carotid arteries (CI). All pts were treated with disease modifying antirheumatic drugs, 65.6% were on steroids (<10 mg/day), and 27.8% were on biological therapy. IR was calculated using the updated-computer Homeostasis Model Assessment (HOMA2-IR), based on fasting plasma glucose and serum specific insulin concentrations (measured by ELISA). Insulin resistance was defined as HOMA2-IR>1.

Results: Insulin resistance was detected in 74.4% of pts with median value of 1.4 (range 1.0-2.3). Pts with insulin resistance compared to those without this condition had increased IMT (mm) at all levels of carotid arteries. CCAmax: 0.841±0.144 vs. 0.762±0.105 (p=0.018); CCAmean 0.740±0.129 vs. 0.653±0.097, p=0.004; BFmax: 1.059±0.169 vs. 0.920±0.124, p=0.001; BFmean: 0.908±0.141 vs. 0.782±0.126, p=0.000; CImax: 0.678±0.085 vs. 0.620±0.121, p=0.014; CImean: 0.599±0.077 vs. 0.553±0.091, p=0.020. Both groups were comparable regarding RA duration and anti-inflammatory treatment including glycocorticoids. In multivariate logistic regression adjusted for age, BMI, WC, and triglycerides we found that statistical significance disappeared for CCA and CI but stil persisted for BF (e.g. for age BFmax β coef. 4.479, p=0.030; BFmean: β coef. 6.516, p=0.017). In univariant regression analysis, we revealed predictive value of logHOMA2-IR for IMT BFmax:  β coef. 0.253, p=0.001; BFmean: β coef. 0.178, p= 0.006; CImax: β coef 0.097 p=0.026; while for other levels statistical significance was borderline (for CImean and CCAmeanp=0.052, and for CCAmax p=0.064). On the other hand we found significant association of logHOMA2-IR with disease activity: DAS28 β coef 0.034, p=0.037.

Conclusion: RA pts with insulin resistance had significantly increased carotid IMT at all evaluated levels. Significant difference persisted for carotid BF even after adjustment for well known risk factors for atherosclerosis. Significant association of insulin resistance and disease activity may indicate the important role of RA itself in the interplay of IR and atherosclerosis.


Disclosure: G. Ristic, None; V. Subota, None; T. Lepic, None; D. Stanisavljevic, None; B. Glisic, None; M. Petronijevic, None; A. Ristic, None; D. Stefanovic, None.

To cite this abstract in AMA style:

Ristic G, Subota V, Lepic T, Stanisavljevic D, Glisic B, Petronijevic M, Ristic A, Stefanovic D. The Role of Insulin Resistance in the Development of Premature Atherosclerosis in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-role-of-insulin-resistance-in-the-development-of-premature-atherosclerosis-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-insulin-resistance-in-the-development-of-premature-atherosclerosis-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology